Together, these data suggest that CQ-reset macrophages ameliorate the immunosuppressive tumor immune microenvironment through a lysosomal calcium-TFEB pathway, and combining other immune therapeutics with CQ can further potentiate its beneficial effect on the immunosuppressive tumor microenvironment. The gene discussed is TFEB; the disease is neoplasm.